Revision history of "Spray4MED.: Study and development of biocompatible formulations with controlled release of antiviral compounds, prolonged protection for surface and dermal application." (Q2889252)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2024

14 June 2023

10 June 2023

23 May 2023

8 November 2022

29 July 2022

  • curprev 13:3713:37, 29 July 2022DG Regio talk contribs 42,801 bytes +26,029 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, nl, fr, de, it, pt, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv,

20 January 2022

17 January 2022

19 December 2021

13 December 2021

5 December 2021

21 October 2021

13 September 2021

8 July 2021

  • curprev 05:3405:34, 8 July 2021DG Regio talk contribs 9,426 bytes +228 Changed label, description and/or aliases in en: translated_label
  • curprev 05:3405:34, 8 July 2021DG Regio talk contribs 9,198 bytes +1,108 Created claim: summary (P836): In the fight against the COVID-19 pandemic, the Spray4MED project aims to develop a biocompatible formulation of antiviral protection with prolonged effect over time. Cell4MED proposes the investigation of solutions to address the limitations of disinfectants available and widely used., translated_summary

7 July 2021

6 July 2021